Unknown

Dataset Information

0

Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome.


ABSTRACT: Although several risk factors exist for acute coronary syndrome (ACS) no biomarkers for survival or risk of re-infarction have been validated. Previously, reduced serum concentrations of anti-ß1AR Ab have been implicated in poorer ACS outcomes. This study further evaluates the prognostic implications of anti-ß1AR-Ab levels at the time of ACS onset. Serum anti-ß1AR Ab concentrations were measured in randomly selected patients from within the PLATO cohort. Stratification was performed according to ACS event: ST-elevation myocardial infarct (STEMI) vs. non-ST elevation myocardial infarct (NSTEMI). Antibody concentrations at ACS presentation were compared to 12-month all-cause and cardiovascular mortality, as well as 12-month re-infarction. Sub-analysis, stratifying for age and the correlation between antibody concentration and conventional cardiac risk-factors was subsequently performed. Serum anti-ß1AR Ab concentrations were measured in 400/799 (50%) STEMI patients and 399 NSTEMI patients. Increasing anti-ß1AR Ab concentrations were associated with STEMI (p?=?0.001). Across all ACS patients, no associations between anti-ß1AR Ab concentration and either all-cause cardiovascular death or myocardial re-infarction (p?=?0.14) were evident. However among STEMI patients ?60 years with anti-ß1AR Ab concentration 1AR Ab concentrations?>?median (14/198 (7.1%) vs. 2/190 (1.1%)); p?=?0.01). Similarly, the same sub-group demonstrated greater risk of cardiovascular death in year 1, including re-infarction and stroke (22/198 (11.1%) vs. 10/190 (5.3%); p?=?0.017). ACS Patients ?60 years, exhibiting lower concentrations of ß1AR Ab carry a greater risk for early re-infarction and cardiovascular death. Large, prospective studies quantitatively assessing the prognostic relevance of Anti-ß1AR Ab levels should be considered.

SUBMITTER: Ernst D 

PROVIDER: S-EPMC6787077 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome.

Ernst Diana D   Westerbergh Johan J   Sogkas Georgios G   Jablonka Alexandra A   Ahrenstorf Gerrit G   Schmidt Reinhold Ernst RE   Heidecke Harald H   Wallentin Lars L   Riemekasten Gabriela G   Witte Torsten T  

Scientific reports 20191010 1


Although several risk factors exist for acute coronary syndrome (ACS) no biomarkers for survival or risk of re-infarction have been validated. Previously, reduced serum concentrations of anti-ß<sub>1</sub>AR Ab have been implicated in poorer ACS outcomes. This study further evaluates the prognostic implications of anti-ß<sub>1</sub>AR-Ab levels at the time of ACS onset. Serum anti-ß<sub>1</sub>AR Ab concentrations were measured in randomly selected patients from within the PLATO cohort. Stratifi  ...[more]

Similar Datasets

| S-EPMC9410591 | biostudies-literature
| S-EPMC9248272 | biostudies-literature
| S-EPMC2779411 | biostudies-literature
| S-EPMC3006621 | biostudies-literature
| S-EPMC5126349 | biostudies-literature
| S-EPMC2923055 | biostudies-literature
| S-EPMC5642626 | biostudies-literature
| S-EPMC6305491 | biostudies-literature
| S-EPMC1952636 | biostudies-literature
| S-EPMC2242685 | biostudies-literature